Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Negative affect moderates the effect of social rejection on frontal and anterior cingulate cortex activation in borderline personality disorder.

Wrege JS, Ruocco AC, Euler S, Preller KH, Busmann M, Meya L, Schmidt A, Lang UE, Borgwardt S, Walter M.

Cogn Affect Behav Neurosci. 2019 Jun 4. doi: 10.3758/s13415-019-00716-0. [Epub ahead of print]

PMID:
31165440
2.

Improvement of Emotional Empathy and Cluster B Personality Disorder Symptoms Associated With Decreased Cocaine Use Severity.

Vonmoos M, Eisenegger C, Bosch OG, Preller KH, Hulka LM, Baumgartner M, Seifritz E, Quednow BB.

Front Psychiatry. 2019 Apr 5;10:213. doi: 10.3389/fpsyt.2019.00213. eCollection 2019.

3.

Effective connectivity changes in LSD-induced altered states of consciousness in humans.

Preller KH, Razi A, Zeidman P, Stämpfli P, Friston KJ, Vollenweider FX.

Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2743-2748. doi: 10.1073/pnas.1815129116. Epub 2019 Jan 28.

4.

Longitudinal changes in cocaine intake and cognition are linked to cortical thickness adaptations in cocaine users.

Hirsiger S, Hänggi J, Germann J, Vonmoos M, Preller KH, Engeli EJE, Kirschner M, Reinhard C, Hulka LM, Baumgartner MR, Chakravarty MM, Seifritz E, Herdener M, Quednow BB.

Neuroimage Clin. 2019;21:101652. doi: 10.1016/j.nicl.2019.101652. Epub 2019 Jan 4.

5.

Cognitive and neuroanatomical impairments associated with chronic exposure to levamisole-contaminated cocaine.

Vonmoos M, Hirsiger S, Preller KH, Hulka LM, Allemann D, Herdener M, Baumgartner MR, Quednow BB.

Transl Psychiatry. 2018 Oct 27;8(1):235. doi: 10.1038/s41398-018-0279-3.

6.

Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor.

Preller KH, Burt JB, Ji JL, Schleifer CH, Adkinson BD, Stämpfli P, Seifritz E, Repovs G, Krystal JH, Murray JD, Vollenweider FX, Anticevic A.

Elife. 2018 Oct 25;7. pii: e35082. doi: 10.7554/eLife.35082.

7.

Psychedelics and music: neuroscience and therapeutic implications.

Barrett FS, Preller KH, Kaelen M.

Int Rev Psychiatry. 2018 Sep 21:1-13. doi: 10.1080/09540261.2018.1484342. [Epub ahead of print]

PMID:
30240282
8.

Thinking about the past to shape the present: neural activation during the recall of relationship episodes.

Wade-Bohleber LM, Boeker H, Ernst J, Grimm S, Brügger N, Berwian IM, Vetter J, Preller KH, Himmighoffen H, Kleim B, Seifritz E, Richter A.

Behav Brain Res. 2019 Feb 1;359:783-791. doi: 10.1016/j.bbr.2018.08.001. Epub 2018 Aug 2.

PMID:
30077577
9.

Socio-cognitive functioning in stimulant polysubstance users.

Kroll SL, Wunderli MD, Vonmoos M, Hulka LM, Preller KH, Bosch OG, Baumgartner MR, Quednow BB.

Drug Alcohol Depend. 2018 Sep 1;190:94-103. doi: 10.1016/j.drugalcdep.2018.06.001. Epub 2018 Jun 30.

PMID:
30005311
10.

Glucocorticoid receptor gene variants and lower expression of NR3C1 are associated with cocaine use.

Schote AB, Jäger K, Kroll SL, Vonmoos M, Hulka LM, Preller KH, Meyer J, Grünblatt E, Quednow BB.

Addict Biol. 2019 Jul;24(4):730-742. doi: 10.1111/adb.12632. Epub 2018 May 15.

PMID:
29761890
11.

Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.

Grimm O, Kraehenmann R, Preller KH, Seifritz E, Vollenweider FX.

Eur Neuropsychopharmacol. 2018 Jun;28(6):691-700. doi: 10.1016/j.euroneuro.2018.03.016. Epub 2018 Apr 25.

PMID:
29703645
12.

Role of the 5-HT2A Receptor in Self- and Other-Initiated Social Interaction in Lysergic Acid Diethylamide-Induced States: A Pharmacological fMRI Study.

Preller KH, Schilbach L, Pokorny T, Flemming J, Seifritz E, Vollenweider FX.

J Neurosci. 2018 Apr 4;38(14):3603-3611. doi: 10.1523/JNEUROSCI.1939-17.2018. Epub 2018 Mar 19.

13.

Risk preference and choice stochasticity during decisions for other people.

Rigoli F, Preller KH, Dolan RJ.

Cogn Affect Behav Neurosci. 2018 Apr;18(2):331-341. doi: 10.3758/s13415-018-0572-x.

14.

LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.

Kraehenmann R, Pokorny D, Aicher H, Preller KH, Pokorny T, Bosch OG, Seifritz E, Vollenweider FX.

Front Pharmacol. 2017 Nov 8;8:814. doi: 10.3389/fphar.2017.00814. eCollection 2017.

15.

Serotonin 2A Receptor Signaling Underlies LSD-induced Alteration of the Neural Response to Dynamic Changes in Music.

Barrett FS, Preller KH, Herdener M, Janata P, Vollenweider FX.

Cereb Cortex. 2018 Nov 1;28(11):3939-3950. doi: 10.1093/cercor/bhx257.

PMID:
29028939
16.

Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow.

Lewis CR, Preller KH, Kraehenmann R, Michels L, Staempfli P, Vollenweider FX.

Neuroimage. 2017 Oct 1;159:70-78. doi: 10.1016/j.neuroimage.2017.07.020. Epub 2017 Jul 12.

PMID:
28711736
17.

Erratum to: Phenomenology, Structure, and Dynamic of Psychedelic States.

Preller KH, Vollenweider FX.

Curr Top Behav Neurosci. 2018;36:1. doi: 10.1007/7854_2017_477. No abstract available.

PMID:
28710675
18.

Effect of Psilocybin on Empathy and Moral Decision-Making.

Pokorny T, Preller KH, Kometer M, Dziobek I, Vollenweider FX.

Int J Neuropsychopharmacol. 2017 Sep 1;20(9):747-757. doi: 10.1093/ijnp/pyx047.

19.

Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation.

Kraehenmann R, Pokorny D, Vollenweider L, Preller KH, Pokorny T, Seifritz E, Vollenweider FX.

Psychopharmacology (Berl). 2017 Jul;234(13):2031-2046. doi: 10.1007/s00213-017-4610-0. Epub 2017 Apr 7.

20.

Neural underpinnings of prosexual effects induced by gamma-hydroxybutyrate in healthy male humans.

Bosch OG, Havranek MM, Baumberger A, Preller KH, von Rotz R, Herdener M, Kraehenmann R, Staempfli P, Scheidegger M, Klucken T, Seifritz E, Quednow BB.

Eur Neuropsychopharmacol. 2017 Apr;27(4):372-382. doi: 10.1016/j.euroneuro.2017.02.006. Epub 2017 Mar 8.

21.

Stable self-serving personality traits in recreational and dependent cocaine users.

Quednow BB, Hulka LM, Preller KH, Baumgartner MR, Eisenegger C, Vonmoos M.

PLoS One. 2017 Mar 2;12(3):e0172853. doi: 10.1371/journal.pone.0172853. eCollection 2017.

22.

Dynamic causal modelling revisited.

Friston KJ, Preller KH, Mathys C, Cagnan H, Heinzle J, Razi A, Zeidman P.

Neuroimage. 2017 Feb 17. pii: S1053-8119(17)30156-8. doi: 10.1016/j.neuroimage.2017.02.045. [Epub ahead of print]

23.

The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation.

Preller KH, Herdener M, Pokorny T, Planzer A, Kraehenmann R, Stämpfli P, Liechti ME, Seifritz E, Vollenweider FX.

Curr Biol. 2017 Feb 6;27(3):451-457. doi: 10.1016/j.cub.2016.12.030. Epub 2017 Jan 26.

24.

Phenomenology, Structure, and Dynamic of Psychedelic States.

Preller KH, Vollenweider FX.

Curr Top Behav Neurosci. 2018;36:221-256. doi: 10.1007/7854_2016_459. Review. Erratum in: Curr Top Behav Neurosci. 2017 Jul 15;:.

PMID:
28025814
25.

Effects of serotonin 2A/1A receptor stimulation on social exclusion processing.

Preller KH, Pokorny T, Hock A, Kraehenmann R, Stämpfli P, Seifritz E, Scheidegger M, Vollenweider FX.

Proc Natl Acad Sci U S A. 2016 May 3;113(18):5119-24. doi: 10.1073/pnas.1524187113. Epub 2016 Apr 18.

26.

Cognitive and emotional impairments in adults with attention-deficit/hyperactivity disorder and cocaine use.

Wunderli MD, Vonmoos M, Niedecker SM, Hulka LM, Preller KH, Baumgartner MR, Kraemer T, Seifritz E, Schaub MP, Eich-Höchli D, Quednow BB.

Drug Alcohol Depend. 2016 Jun 1;163:92-9. doi: 10.1016/j.drugalcdep.2016.03.026. Epub 2016 Apr 7.

PMID:
27085500
27.

Shared neural basis of social and non-social reward deficits in chronic cocaine users.

Tobler PN, Preller KH, Campbell-Meiklejohn DK, Kirschner M, Kraehenmann R, Stämpfli P, Herdener M, Seifritz E, Quednow BB.

Soc Cogn Affect Neurosci. 2016 Jun;11(6):1017-25. doi: 10.1093/scan/nsw030. Epub 2016 Mar 12.

28.

The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.

Kraehenmann R, Schmidt A, Friston K, Preller KH, Seifritz E, Vollenweider FX.

Neuroimage Clin. 2015 Aug 22;11:53-60. doi: 10.1016/j.nicl.2015.08.009. eCollection 2016.

29.

Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.

Pokorny T, Preller KH, Kraehenmann R, Vollenweider FX.

Eur Neuropsychopharmacol. 2016 Apr;26(4):756-66. doi: 10.1016/j.euroneuro.2016.01.005. Epub 2016 Jan 22.

PMID:
26875114
30.

α2A -Adrenergic receptor polymorphisms and mRNA expression levels are associated with delay discounting in cocaine users.

Havranek MM, Hulka LM, Tasiudi E, Eisenegger C, Vonmoos M, Preller KH, Mössner R, Baumgartner MR, Seifritz E, Grünblatt E, Quednow BB.

Addict Biol. 2017 Mar;22(2):561-569. doi: 10.1111/adb.12324. Epub 2015 Nov 8.

31.

Changes in cocaine consumption are associated with fluctuations in self-reported impulsivity and gambling decision-making.

Hulka LM, Vonmoos M, Preller KH, Baumgartner MR, Seifritz E, Gamma A, Quednow BB.

Psychol Med. 2015 Oct;45(14):3097-110. doi: 10.1017/S0033291715001063. Epub 2015 Jun 17.

PMID:
26081043
32.

Serotonin Transporter and Tryptophan Hydroxylase Gene Variations Mediate Working Memory Deficits of Cocaine Users.

Havranek MM, Vonmoos M, Müller CP, Büetiger JR, Tasiudi E, Hulka LM, Preller KH, Mössner R, Grünblatt E, Seifritz E, Quednow BB.

Neuropsychopharmacology. 2015 Dec;40(13):2929-37. doi: 10.1038/npp.2015.146. Epub 2015 May 27.

33.

Glutamatergic and neurometabolic alterations in chronic cocaine users measured with (1) H-magnetic resonance spectroscopy.

Hulka LM, Scheidegger M, Vonmoos M, Preller KH, Baumgartner MR, Herdener M, Seifritz E, Henning A, Quednow BB.

Addict Biol. 2016 Jan;21(1):205-17. doi: 10.1111/adb.12217. Epub 2014 Dec 30.

34.

Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects.

Schmid Y, Enzler F, Gasser P, Grouzmann E, Preller KH, Vollenweider FX, Brenneisen R, Müller F, Borgwardt S, Liechti ME.

Biol Psychiatry. 2015 Oct 15;78(8):544-53. doi: 10.1016/j.biopsych.2014.11.015. Epub 2014 Nov 29.

PMID:
25575620
35.

Effects of methylphenidate and MDMA on appraisal of erotic stimuli and intimate relationships.

Schmid Y, Hysek CM, Preller KH, Bosch OG, Bilderbeck AC, Rogers RD, Quednow BB, Liechti ME.

Eur Neuropsychopharmacol. 2015 Jan;25(1):17-25. doi: 10.1016/j.euroneuro.2014.11.020. Epub 2014 Dec 4.

36.

Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.

Kraehenmann R, Preller KH, Scheidegger M, Pokorny T, Bosch OG, Seifritz E, Vollenweider FX.

Biol Psychiatry. 2015 Oct 15;78(8):572-81. doi: 10.1016/j.biopsych.2014.04.010. Epub 2014 Apr 26.

PMID:
24882567
37.

Influence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometry.

Csomor PA, Preller KH, Geyer MA, Studerus E, Huber T, Vollenweider FX.

Neuropsychopharmacology. 2014 Sep;39(10):2485-96. doi: 10.1038/npp.2014.102. Epub 2014 May 7.

38.

Cognitive impairment in cocaine users is drug-induced but partially reversible: evidence from a longitudinal study.

Vonmoos M, Hulka LM, Preller KH, Minder F, Baumgartner MR, Quednow BB.

Neuropsychopharmacology. 2014 Aug;39(9):2200-10. doi: 10.1038/npp.2014.71. Epub 2014 Mar 21.

39.

Functional changes of the reward system underlie blunted response to social gaze in cocaine users.

Preller KH, Herdener M, Schilbach L, Stämpfli P, Hulka LM, Vonmoos M, Ingold N, Vogeley K, Tobler PN, Seifritz E, Quednow BB.

Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2842-7. doi: 10.1073/pnas.1317090111. Epub 2014 Jan 21.

40.

MDMA enhances emotional empathy and prosocial behavior.

Hysek CM, Schmid Y, Simmler LD, Domes G, Heinrichs M, Eisenegger C, Preller KH, Quednow BB, Liechti ME.

Soc Cogn Affect Neurosci. 2014 Nov;9(11):1645-52. doi: 10.1093/scan/nst161. Epub 2013 Oct 4.

41.

Cocaine users manifest impaired prosodic and cross-modal emotion processing.

Hulka LM, Preller KH, Vonmoos M, Broicher SD, Quednow BB.

Front Psychiatry. 2013 Sep 5;4:98. doi: 10.3389/fpsyt.2013.00098. eCollection 2013.

42.

Altered social and non-social decision-making in recreational and dependent cocaine users.

Hulka LM, Eisenegger C, Preller KH, Vonmoos M, Jenni D, Bendrick K, Baumgartner MR, Seifritz E, Quednow BB.

Psychol Med. 2014 Apr;44(5):1015-28. doi: 10.1017/S0033291713001839. Epub 2013 Jul 22.

43.

Differences in self-reported and behavioral measures of impulsivity in recreational and dependent cocaine users.

Vonmoos M, Hulka LM, Preller KH, Jenni D, Schulz C, Baumgartner MR, Quednow BB.

Drug Alcohol Depend. 2013 Nov 1;133(1):61-70. doi: 10.1016/j.drugalcdep.2013.05.032. Epub 2013 Jun 24.

44.

Impaired emotional empathy and related social network deficits in cocaine users.

Preller KH, Hulka LM, Vonmoos M, Jenni D, Baumgartner MR, Seifritz E, Dziobek I, Quednow BB.

Addict Biol. 2014 May;19(3):452-66. doi: 10.1111/adb.12070. Epub 2013 Jun 25.

45.

Cognitive dysfunctions in recreational and dependent cocaine users: role of attention-deficit hyperactivity disorder, craving and early age at onset.

Vonmoos M, Hulka LM, Preller KH, Jenni D, Baumgartner MR, Stohler R, Bolla KI, Quednow BB.

Br J Psychiatry. 2013 Jul;203(1):35-43. doi: 10.1192/bjp.bp.112.118091. Epub 2013 May 23.

46.

Smoking but not cocaine use is associated with lower cerebral metabotropic glutamate receptor 5 density in humans.

Hulka LM, Treyer V, Scheidegger M, Preller KH, Vonmoos M, Baumgartner MR, Johayem A, Ametamey SM, Buck A, Seifritz E, Quednow BB.

Mol Psychiatry. 2014 May;19(5):625-32. doi: 10.1038/mp.2013.51. Epub 2013 Apr 30.

47.

Sustained incentive value of heroin-related cues in short- and long-term abstinent heroin users.

Preller KH, Wagner M, Sulzbach C, Hoenig K, Neubauer J, Franke PE, Petrovsky N, Frommann I, Rehme AK, Quednow BB.

Eur Neuropsychopharmacol. 2013 Oct;23(10):1270-9. doi: 10.1016/j.euroneuro.2012.11.007. Epub 2012 Dec 7.

PMID:
23219936
48.

Increased sensorimotor gating in recreational and dependent cocaine users is modulated by craving and attention-deficit/hyperactivity disorder symptoms.

Preller KH, Ingold N, Hulka LM, Vonmoos M, Jenni D, Baumgartner MR, Vollenweider FX, Quednow BB.

Biol Psychiatry. 2013 Feb 1;73(3):225-34. doi: 10.1016/j.biopsych.2012.08.003. Epub 2012 Sep 5.

49.

Blue-yellow colour vision impairment and cognitive deficits in occasional and dependent stimulant users.

Hulka LM, Wagner M, Preller KH, Jenni D, Quednow BB.

Int J Neuropsychopharmacol. 2013 Apr;16(3):535-47. doi: 10.1017/S1461145712000624. Epub 2012 Jun 18.

Supplemental Content

Loading ...
Support Center